/Vir Biotechnology targets fourth-quarter 2026 for ECLIPSE 1 clinical trial readout/SoftBank fiscal first-quarter profit tops expectations on Intel and ByteDance holdings/Lucid stock plunges as EV maker begins operational reset, delays midsize vehicle/Russian forces strike two vessels near Odesa, defence ministry says/Warrior Met Coal targets 5 million tons of Blue Creek sales in 2026, lifts full-year guidance/BDRXF declares CAD 0.390625 quarterly cash dividend, payable Nov. 2/Vir Biotechnology targets fourth-quarter 2026 for ECLIPSE 1 clinical trial readout/SoftBank fiscal first-quarter profit tops expectations on Intel and ByteDance holdings/Lucid stock plunges as EV maker begins operational reset, delays midsize vehicle/Russian forces strike two vessels near Odesa, defence ministry says/Warrior Met Coal targets 5 million tons of Blue Creek sales in 2026, lifts full-year guidance/BDRXF declares CAD 0.390625 quarterly cash dividend, payable Nov. 2